Hai-Liang Li
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (20 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers)Renal cell carcinoma treatment (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaFrontiers in ImmunologyExperimental Cell Research
- Partner nations
- ChinaSouth KoreaSaudi Arabia
In The Last Decade
Hai-Liang Li
38 papers receiving 351 citations
Peers
Comparison fields: 5 of 86
- Hepatology 112
- Surgery 92
- Molecular Biology 75
- Epidemiology 70
- Pathology and Forensic Medicine 64
Countries citing papers authored by Hai-Liang Li
This map shows the geographic impact of Hai-Liang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai-Liang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai-Liang Li more than expected).
Fields of papers citing papers by Hai-Liang Li
This network shows the impact of papers produced by Hai-Liang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai-Liang Li. The network helps show where Hai-Liang Li may publish in the future.
Co-authorship network of co-authors of Hai-Liang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Hai-Liang Li. A scholar is included among the top collaborators of Hai-Liang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai-Liang Li. Hai-Liang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 7 | |
| 11 | 12 | |
| 12 | 29 | |
| 13 | 9 | |
| 14 | 9 | |
| 15 | 16 | |
| 16 | 24 | |
| 17 | 1 | |
| 18 | 4 | |
| 19 | 6 | |
| 20 | 0 |
About Hai-Liang Li
Hai-Liang Li is a scholar working on Hepatology, Obstetrics and Gynecology and Surgery, having authored 43 papers that have together received 353 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Hepatology (112 citations), Pathology and Forensic Medicine (64 citations) and Cancer Research (48 citations). Hai-Liang Li has collaborated with scholars based in China, South Korea and Saudi Arabia. Frequent co-authors include Hongtao Hu, Chenyang Guo, Junli Ma, Zheng Lin, Hong-Tao Hu, Erjiang Zhao, Shiqing Feng, Hong Xu, Chengshi Chen and Jiang Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.